Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas Source: Eur Respir J 2004; 24: Suppl. 48, 557s Year: 2004
Clinical characteristics of large cell neuroendocrine carcinoma of the lung Source: Eur Respir J 2004; 24: Suppl. 48, 531s Year: 2004
Treatment for thymic epithelial Source: International Congress 2016 – PG20 Thymic tumours Year: 2016
Clinical diagnosis of thymic gland diseases Source: Eur Respir J 2003; 22: Suppl. 45, 368s Year: 2003
Prognosis of thymic epithelial tumors according to the new world health organization histologic classification Source: Annual Congress 2004 - Prognostic factors Year: 2004
Surgery in thymic tumours Source: International Congress 2016 – PG20 Thymic tumours Year: 2016
Cytological characteristics of pulmonary large cell neuroendocrine carcinoma Source: Eur Respir J 2004; 24: Suppl. 48, 82s Year: 2004
Clinicopathologic features, histologic and immunohistochemical characteristics, and clinical outcome of patients with cardiac myofibroblastic tumors Source: Annual Congress 2009 - Pleural and mediastinal diseases Year: 2009
Clinicopathologic characteristics of primary bronchial cancer metastasizing to the brain Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients Year: 2011
Immunophenotypic and functional characterization of adult lung epithelial and stromal progenitor cell targets Source: Annual Congress 2008 - Regulatory mechanisms of cell activation, renewal and recruitment Year: 2008
Bronchioalveolar lung carcinoma: its clinical, radiological and pathological features Source: Eur Respir J 2006; 28: Suppl. 50, 90s Year: 2006
Potential prognostic factors in typical and atypical carcinoid tumours of the lung - immunhistochemical investigations Source: Eur Respir J 2001; 18: Suppl. 33, 229s Year: 2001
Clinical characterization of non-small cell lung cancer tumors showing neuroendocrine differentiation Source: Eur Respir J 2002; 20: Suppl. 38, 270s Year: 2002
Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: clinical characteristics and progression to carcinoid tumour Source: Eur Respir J, 59 (1) 2101058; 10.1183/13993003.01058-2021 Year: 2022
Influence mesenchymal stem cells on aneuploidy of the tumor cells of Lewis lung carcinoma Source: International Congress 2019 – Biology of lung cancer Year: 2019
Clinical prognostic indicators of high-grade pre-invasive bronchial lesions Source: Eur Respir J 2004; 24: 24-29 Year: 2004